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mental design may under  lie observed differ­
ences in sensitivity to detect neuro  toxicity, 
possibly because of differences in bio  kinetics 
and exposure during sensitive windows of 
development. Fortunately, much effort is tak­
ing place in the scientific community to opti­
mize experi  mental designs at different levels 
of biological complexity, including (develop­
mental) neuro  behavioral studies. Although 
a critical review on the impact of different 
experi  mental designs for in vivo (developmen­
tal) neuro  toxicity studies would be very use­
ful, it was beyond the scope of our review 
(Dingemans et al. 2011). 
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Three Criteria for Ecological Fallacy
doi:10.1289/ehp.1103768
In a large cohort study published in 
Environmental Health Perspectives, Brenner 
et al. (2011) confirmed previous results on 
I­131 exposure and thyroid cancer among 
a Ukranian population. According to 
the authors, one motivation to study this 
associa  tion was based on evidence from eco­
logical studies (Jacob et al. 1999) with two 
methodo  logical limitations: use of grouped 
doses and poor control of confounding. 
With these new findings, evidence from eco­
logical, case–control, and cohort studies are 
consistent; thus, an interesting question is 
whether there was an ecological fallacy.
Although ecological studies are important 
to epidemiology (especially in environmental 
and social epidemiology), public health prac­
titioners seem afraid of ecological studies. It is 
a common practice to assume the presence of 
ecological fallacy (Robinson 1950) and low­
level validity when analyzing an ecological 
study. Most epidemiologists prefer an exclu­
sive individualistic approach, although the 
importance of a multi  level causal approach 
is widely recognized (Diez­Roux 2002). In 
this sense, some authors suggest that it is as 
important to recognize the presence of eco­
logical fallacy as to recognize psychologistic 
or individualistic fallacy (Subramanian et al. 
2009) (Figure 1).
Thus, it is necessary to have clear guide­
lines on when there is or not an ecological 
fallacy. In this sense, I propose three criteria 
for the identification of ecological fallacy; all 





One use of ecological studies is to explore   
individual­level association when individual 
data are not available. When the focus of 
the study was contextual or based on popu­
la  tion effects and there is no inference to 
individuals, ecological fallacy is not pos­
sible. When only the first two criteria are 
present—which is insufficient to affirm eco­
logical fallacy—it is appropriate to acknowl­
edge that there is a possible relation  ship and 
that further study is required. 
•	Results	obtained	with	individual	data	are	
contradictory. 
Only when empirical data are available is 
it possible to confirm that an ecological fallacy 
is present. 
The author declares that he has no competing 
financial interests.
Alvaro J. Idrovo
Center for Health Systems Research
National Institute of Public Health
Cuernavaca, Morelos, Mexico 
E­mail: javier.idrovo@insp.mx
RefeRences
Brenner AV, Tronko MD, Hatch M, Bogdanova TI, Oliynik VA, 
Lubin JH, et al. 2011. I-131 dose response for incident 
thyroid cancers in Ukraine related to the Chornobyl acci-
dent. Environ Health Perspect 119:933–939; doi:10.1289/
ehp.1002674 [Online 17 March 2011].
Diez-Roux AV. 2002. A glossary for multilevel analysis. 
J Epidemiol Community Health 56(8):588–594.
Jacob P, Kenigsberg Y, Zvonova I, Goulko G, Buglova E, 
Heidenreich WF, et al. 1999. Childhood exposure due 
to the Chernobyl accident and thyroid cancer risk in 
contaminated areas of Belarus and Russia. Br J Cancer 
80(9):1461–1469.
Robinson WS. 1950. Ecological correlations and the behavior 
of individuals. Am Sociol Rev 15(3):351–357.
Subramanian SV, Jones K, Kaddour A, Krieger N. 2009. 
Revisiting Robinson: the perils of individualistic and eco-
logic fallacy. Int J Epidemiol 38(2):342–360.
Carbon Black
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In “Research Recommendations for Selected 
IARC­Classified Agents,” Ward et al. (2010) 
identified research gaps for 20 occupational 
agents “based on evidence of widespread 
human exposures and potential carcino­
genicity in animals or humans.” (Ward 
et al. 2010) For carbon black, the authors   
suggested that
Research needs include updating epidemiology 
cohorts with data on work histories and exposures 
in relation to particle size and surface area, and 
recruitment of additional carbon black facilities. 
The relationship between occupational exposure 
to carbon black and validated bio  markers of oxi­
dative stress should be examined and exposure–
response relationships in humans and rodents 
quantified, including the role of particle size. 
Ward et al. (2010) referred to a study of 
British carbon black workers in which carbon 
black was suggested as a possible “late stage 
carcinogen” (Sorahan and Harrington 2007). 
In that study, Sorahan and Harrington 
(2007) called for similar analyses of other 
carbon black cohorts (i.e., evaluating the 
possibility of carbon black acting as a late 
stage carcinogen via the concept of “lugging,” 
which considers only recent exposures and 
not historical exposures). In response to sug­
gestions made by Sorahan and Harrington, 
we conducted such analyses on a large 
German carbon black cohort (Morfeld and 
McCunney 2007, 2009). We were unable to 
reproduce the results of the British analysis, 
despite the elevation noted in lung cancer 
among German cohort workers, thus pro­
viding no support for the late stage­lugging 
hypothesis. Results of a detailed analysis of 
the German cohort using Bayesian meth­
odology showed smoking and exposure to 
occupational carcinogens prior to work at 
the carbon black plant as confounders prob­
ably responsible for the lung cancer excess 
(Morfeld and McCunney 2010). 
Ward et al. (2010) called for enhanced 
exposure–response assessments in humans. 
Currently, a dose–response exposure analy  sis 
is under way on the U.S. carbon black cohort 
(> 5,000 production workers). An earlier 
evaluation of this cohort showed no increase 
in any type of cancer (Dell et al. 2006). 
Figure 1. Levels of analysis in epidemiologic studies 
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Ward et al. (2010) recommended that 
“the relation  ship between occupational expo­
sure to carbon black and validated bio  markers 
of oxidative stress should be examined.” 
Despite the appeal of biomarkers of oxidative 
stress in pinpointing inflammatory changes 
associated with malignant and non  malignant 
illnesses, such markers are non  specific, not 
well validated, and appear not “ready for 
prime time,” as noted in a recent symposium 
on nano  toxicology (Fischman et al. 2011). 
A meta­analysis of all three major car­
bon black cohorts (United States, United 
Kingdom, and Germany) to assess risk of 
heart disease is also under way. In a recent 
position paper, Brook et al. (2004) noted 
that particle exposure may play a role in the 
develop  ment of heart disease. 
Ward et al. (2010) suggested evaluating 
carbon black particle size and surface area. 
However, the physi  cal and chemical proper­
ties of untreated manufactured carbon blacks 
are distinctly different from ubiquitous car­
bon core particulates in both occupational 
and ambient atmospheres (Kuhlbusch and 
Fissan 2006). Approximately 90% of manu­
factured carbon black is used for tire and 
automotive rubber products. In products, 
such as toners, plastics, and surface coatings, 
carbon black is matrix­bound, and not an 
exposure risk to end­users. Care should be 
taken when applying quantitative models 
that claim to address the particle size and 
surface area topics (Tomenson and Morfeld 
2010). 
The authors serve as scientific advisors to the 
International Carbon Black Association (ICBA), 
a scientific, non-profit corporation originally 
founded in 1977, with the purpose of sponsor-
ing, conducting, and participating in investi-
gations, research, and analyses relating to the 
health, safety, and environmental aspects of the 
production and use of carbon black. This manu-
script was neither influenced by the ICBA nor 
by any company funding the ICBA, nor does it 
present any view or opinion of the ICBA or of the 
companies. H.M. is president of Muranko and 
Associates, a consulting company that provides 
industrial hygiene and safety services and serves as 
expert witness in industrial safety cases.
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The Scientific Advisory Group of the 
International Carbon Black Association (ICBA) 
gave helpful comments on an earlier version of 
this letter.
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We appreciate the comments and additional 
information from McCunney et al. We are 
pleased to learn of the new epidemiological 
studies that are under way in the U.S. and 
E.U. carbon black cohorts. These studies may 
provide the opportunity to fill some of the 
research gaps discussed in our review (Ward 
et al. 2010). As mentioned by McCunney 
et al. in their letter, we recom  mend the col­
lection of particle size–specific and quantita­
tive exposure data, and the recruitment of 
additional facilities (Ward et al.). Studies in 
animals have shown relationships between 
the particle surface area dose of poorly sol­
uble particles (including carbon black) in 
the lungs and bio  markers of oxidative stress 
and inflamma  tion in rats and mice (Elder 
et al. 2005; Sager and Castranova 2009; 
Stoeger et al. 2006) and lung tumors in rats 
(Driscoll 1996; Heinrich et al. 1995; Nikula 
et al. 1995). Although these relationships 
with particle surface area dose have not been 
reported in human studies, exposure to car­
bon black by particle mass has been associated 
with respiratory effects including lung func­
tion decrements in workers (Gardiner et al. 
2001).
Concerning biomarkers of oxidative 
stress, we think the epidemiology studies 
under way may provide an opportunity to 
investigate and test hypotheses about pos­
sible bio  markers of exposure and response 
to carbon black. As we discussed in our 
paper (Ward et al. 2010), although oxida­
tive stress has been invoked as a mechanism 
in the carcino  genicity of a number of agents 
(including particles such as carbon black), 
methodological challenges to the validation 
of oxidative stress biomarker assays remain. 
To facilitate this process, guidelines have been 
developed to standardize the collection and 
measurement of oxidative stress biomarkers 
in humans (American Thoracic Society 1999; 
Horváth et al. 2005).
We look forward to further reports from 
the carbon black mortality studies, includ­
ing exposure–response analyses, which could 
help fill important occupational health 
research gaps. Well­conducted epidemiologic 
studies will be particularly critical to inform 
carcino  gen classification and risk assessment 
processes.
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